ストックスクリーナーアプリを入手
11.17
0.18%
-0.02
アフターアワーズ：
11.26
0.09
+0.81%
Moonlake Immunotherapeutics (MLTX) 最新ニュース
Will MoonLake Immunotherapeutics stock gain from strong economy2026 world cup usa national team quarterfinals playmakers low block defense odds analysis preview - Улправда
MoonLake Immunotherapeutics (NASDAQ:MLTX) Trading Down 4.3%Time to Sell? - MarketBeat
(MLTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Responsive Playbooks and the MLTX Inflection - Stock Traders Daily
Why MoonLake Immunotherapeutics stock could rally in 2025Long Setup & Smart Investment Allocation Insights - Улправда
Trend Report: Will MoonLake Immunotherapeutics stock gain from strong economyWeekly Trade Analysis & Risk Managed Trade Strategies - Улправда
Will MoonLake Immunotherapeutics stock rally after Fed decisionsEarnings Beat & Free Reliable Trade Execution Plans - Улправда
Can MoonLake Immunotherapeutics stock hit analyst price targetsJuly 2025 Update & Weekly High Momentum Picks - Улправда
MoonLake Immunotherapeutics downgraded to Underperform from Peer Perform at Wolfe Research - MSN
Is MoonLake Immunotherapeutics stock attractive for income investorsMarket Risk Analysis & Real-Time Volume Analysis Alerts - Bölüm Sonu Canavarı
MoonLake Extends Sonelokimab Data in Psoriatic Arthritis: What Investors Should Watch - TipRanks
Will MoonLake Immunotherapeutics stock reach all time highs in 2025 - DonanımHaber
Can MoonLake Immunotherapeutics stock hit record highs againWeekly Trade Summary & Risk Controlled Daily Trade Plans - DonanımHaber
Panic Selling: Will MoonLake Immunotherapeutics stock gain from strong economy2025 Momentum Check & Real-Time Price Movement Reports - Улправда
Can MoonLake Immunotherapeutics stock sustain free cash flow growth2025 Buyback Activity & Reliable Price Action Trade Plans - Улправда
How buybacks impact MoonLake Immunotherapeutics stock valueTrade Volume Summary & Weekly Sector Rotation Insights - Улправда
Did You Lose Money on MoonLake Immunotherapeutics (MLTX)? Levi & Korsinsky Urges Investors to Act Before December 15, 2025 - ACCESS Newswire
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price Down 7.7%Should You Sell? - MarketBeat
Join Class Action to Recover Losses from MoonLake Immunotherapeutics (MLTX)Contact Levi & Korsinsky Before December 15, 2025 - ACCESS Newswire
Contact Levi & Korsinsky by December 15, 2025 Deadline to - GlobeNewswire
MLTX DEADLINE ALERT: Hagens Berman Alerts MoonLake (MLTX) Invest - GuruFocus
2025-12-15 | Lost Money on MoonLake Immunotherapeutics (MLTX)? Join Class Action Before December 15, 2025Contact Levi & Korsinsky | NDAQ:MLTX | Press Release - Stockhouse
MLTX DEADLINE ALERT: Hagens Berman Alerts MoonLake (MLTX) Investors to Today's Lead Plaintiff Deadline in Securities Class Action - marketscreener.com
MoonLake Immunotherapeutics Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights – MLTX - marketscreener.com
DEADLINE ALERT for MLTX, BAX, and JHX: The Law Offices of - GlobeNewswire
MOONLAKE DECEMBER 15th DEADLINE: Bragar Eagel & Squire, - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus
New SueWallSt Podcast Covers MoonLake Immunotherapeutics (MLTX) Class Action - ACCESS Newswire
Portnoy Law Firm Announces Class Action on Behalf of Moonlake Immunotherapeutics, Inc. Investors - GlobeNewswire
Shareholders that lost money on MoonLake Immunotherapeutics(MLTX - GuruFocus
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics - Rutland Herald
Shareholders that lost money on MoonLake Immunotherapeutics(MLTX) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of MoonLake Immunotherapeutics to Contact the Firm Today! - ACCESS Newswire
Deadline Soon: MoonLake Immunotherapeutics (MLTX) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - The AI Journal
2025-12-14 | Class Action Lawsuit Alert: Levi & Korsinsky Reminds MoonLake Immunotherapeutics (MLTX) Investors of December 15, 2025 Deadline | NDAQ:MLTX | Press Release - Stockhouse
MoonLake Immunotherapeutics (MLTX) Valuation After Sonelokimab Phase 3 Setback and Emerging Lawsuits - simplywall.st
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
MLTX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages - GlobeNewswire
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of MoonLake Immunotherapeutics to Contact the Firm Today! - ACCESS Newswire
MLTX DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that MoonLake Investors Have Opportunity to Lead Class Action Lawsuit - TMX Newsfile
2025-12-14 | Did You Lose Money on MoonLake Immunotherapeutics (MLTX)? Levi & Korsinsky Urges Investors to Act Before December 15, 2025 | NDAQ:MLTX | Press Release - Stockhouse
MLTX SECURITIES LAWSUIT: MoonLake Immunotherapeutics Investors Are Notified to Contact BFA Law Before Tomorrow's December 15 Class Action Deadline - marketscreener.com
2025-12-13 | Class Action Lawsuit Alert: Levi & Korsinsky Reminds MoonLake Immunotherapeutics (MLTX) Investors of December 15, 2025 Deadline | NDAQ:MLTX | Press Release - Stockhouse
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price Up 6%Still a Buy? - MarketBeat
Phase 3 Miss and Fraud Suits Could Be A Game Changer For MoonLake Immunotherapeutics (MLTX) - simplywall.st
MLTX 2-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action - GlobeNewswire
MLTX 2-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms - GlobeNewswire Inc.
MLTX DEADLINE: Faruqi & Faruqi Reminds MoonLake Investors of the - GuruFocus
MOONLAKE CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. - GlobeNewswire
MLTX FRAUD UPDATE: Important MoonLake Immunotherapeutics - GlobeNewswire
MLTX Deadline: MLTX Investors with Losses in Excess of $100K Hav - GuruFocus
MoonLake Immunotherapeutics Sued for Securities Law - GlobeNewswire
MLTX Deadline: MLTX Investors with Losses in Excess of $100K Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit - marketscreener.com
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Announces That MoonLake Immunotherapeutics Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - NewMediaWire
MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action LawsuitHagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms - The Malaysian Reserve
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):